Clinical Trials
- Gynecological Cancers
A Randomized, Phase 3, Double-Blind Study of Chemoradiotherapy With or Without Pembrolizumab for the Treatment of High-risk, Locally Advanced Cervical Cancer (KEYNOTE-A18 / ENGOT-cx11)
- Date12/03/2020
- Bladder Cancer, Cancer
Advanced Cardiovascular Magnetic Resonance for Detection of Programmed Cell Death Protein-1 Deficient Myocarditis
- Date10/29/2018
- Liver
Mindfulness to treat fatigue in patients with PBC
- Ages18 years - 75 years
- GenderBoth
- Date07/30/2018
- Gynecological Cancers
A Phase 2 Study of VS-6766 (Dual RAF/MEK Inhibitor) Alone and In Combination With Defactinib (FAK Inhibitor) in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)
- GenderFemale only
- Date10/21/2021
- Lung Cancer
Assessing the Feasibility of a Patient-centered Activity Regimen in Patients With Advanced Stage Lung Cancer
- Date10/17/2018
- Skin/Dermatology
Efficacy and Safety of ANB019 in the Treatment of Subjects with Ichthyosis
- Ages12 years - 75 years
- GenderBoth
- Date08/24/2021
- Gynecological Cancers
A Phase II Evaluation of the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Persistent or Recurrent Endometrial Cancer
- Date06/23/2020
- Lung
Saracatinib (AZD0530) in the Treatment of Patients with Idiopathic Pulmonary Fibrosis
- Ages40 years and older
- GenderBoth
- Date02/26/2021
- Gynecological Cancers
Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3) Using a Novel "Prime and Pull" Strategy
- Ages18 years and older
- GenderFemale only
- Date06/13/2016
- Orthopaedics, Muscle & Bone
KD025-215 and diffuse cutaneous systemic sclerosis
- Ages18 years and older
- GenderBoth
- Date02/08/2021